"The Eco Hide-Away provided a great place for up and coming musicians to connect with other artists and display their talents, while raising awareness for Heart Disease," Dr. Douglas Harrington , CEO of Aviir Diagnostics commented. "Since musicians spend much of their life on the road and often live a fast-paced lifestyle, they understand first-hand the value of Heart Disease prevention."
Aviir Company Overview
Aviir was founded in 2005 by cardiologists and scientists from the Stanford University School of Medicine to focus on the discovery, development and commercialization of innovative diagnostic tests. The biotechnology company specializes in developing proprietary diagnostic tests to assist in identifying patients who are truly at high risk for the development of a cardiac event. Aviir's proprietary MIRISK™ and MIRISK VP™ assessments objectively identify, using a single blood draw, individuals who are at a high risk of experiencing a cardiac event over the next five years. Aviir's CLIA-certified laboratory (Irvine, CA) complements these novel tests with a wide range of additional tests for heart health assessment and therapeutic monitoring of cardiovascular disease and related metabolic disorders – including pharmacogenomic and genetic tests. The company has adopted a unique clinical laboratory service model to provide physicians better diagnostic tools to help improve the cardiovascular health of their patients. The company is privately owned and funded by leading life science venture capital firms. Please visit www.aviir.com for more information.
|SOURCE Aviir Inc.|
Copyright©2012 PR Newswire.
All rights reserved